Not currently recruiting at UCSF
A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Clovis, California and other locations
- Dates
- study startestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Eisai Inc.
- ID
- NCT04763408
- Study Type
- Observational
- Participants
- Expecting 1000 study participants
- Last Updated